What is Dura venous stenosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Duran venous stenosis is a condition characterized by the narrowing or constriction of veins, which can impede normal blood flow and lead to various complications, including post-thrombotic syndrome, as noted in studies such as 1.

Definition and Causes

Duran venous stenosis can develop in various veins throughout the body, including those used for dialysis access in patients with kidney disease. It often results from the formation of scar tissue or thickening of the vein wall, which reduces the vessel's diameter and restricts blood flow. The condition can be associated with the placement of central venous catheters and devices, as discussed in 2.

Symptoms and Diagnosis

Patients with Duran venous stenosis may experience symptoms such as:

  • Swelling
  • Pain
  • A feeling of heaviness in the affected area In dialysis patients, it can lead to inadequate blood flow during treatments. Diagnosis typically involves imaging studies like:
  • Ultrasound
  • Venography
  • MRI

Treatment Options

Treatment options for Duran venous stenosis include:

  • Balloon angioplasty to widen the narrowed vein
  • Stent placement to keep the vein open
  • Surgical revision in severe cases Early detection and intervention are crucial to prevent complications such as complete vein occlusion or thrombosis, as highlighted in 3 and 4. Regular monitoring is recommended for high-risk patients, particularly those undergoing dialysis, to detect stenosis before it causes significant symptoms or complications.

Prevention and Management

Prevention of central vein stenosis is key to avoiding access failure and other complications, and relies upon avoidance of central vein catheter placement and timely placement of arteriovenous fistula in prospective dialysis patients, as noted in 2. The use of anticoagulation therapy, such as low-molecular-weight heparins (LMWHs) or direct oral anticoagulants (DOACs), can help prevent deep vein thrombosis and pulmonary embolism, as discussed in 1, 3, and 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.